| |
| | PATHOLOGY EL: Immunopathology Lecture 2 (Site not responding. Last check: 2007-10-18) |
 | | Improved immunosuppression, control of rejection, HLA matching, and more sensitive methods for crossmatching have resulted in a steady improvement in graft survival during the past decade. |
 | | Hence, a crossmatch is performed just prior to transplantation, testing patient's serum against donor lymphocytes, a convenient source of cells bearing HLA antigens. |
 | | Currently, a 6-month patient survival of 95% is achievable at most centers, despite the fact that criteria for recipient selection have been liberalized to include older individuals and patients with systemic illnesses such as diabetes mellitus. |
| cats.med.uvm.edu /cats_teachingmod/pathology/path301/immunopath/imel/301immu3.htm (1973 words) |
|